In a recent article published in the journal Diabetes Care, researchers from Israel reported on a case of a female adolescent with type 1 diabetes who was intentionally omitting insulin in an attempt to lose weight. The adolescent was treated with an advanced hybrid closed-loop system (AHCL), which is a …
Read More »Abstract The prevalence of diabetes mellitus continues to increase worldwide, and it is a well-established cardiovascular risk factor. Hypertension is also an important cardiovascular risk factor to be controlled and is common among patients with diabetes mellitus. Optimal blood pressure (BP) goals have been the subject of great debate in …
Read More »Sponsored Content Bromocriptine-QR (Cycloset) “is a sympatholytic dopamine D2 agonist for the treatment of type 2 diabetes that has demonstrated rapid (within 1 year) substantial reductions in adverse cardiovascular events in this population by as yet incompletely delineated mechanisms.” This study investigated the impact of Cycloset on the pro-inflammatory state …
Read More »Finerenone, a selective nonsteroidal mineralocorticoid receptor antagonist, improves cardiovascular events (MI, stroke, HF) in Type 2 Diabetes and Chronic Kidney Disease (CKD) patients. Some risk factors for cardiovascular diseases (CVD), such as high blood glucose, blood pressure, serum cholesterol, and BMI, are also associated with CKD and type 2 diabetes. …
Read More »Is there a link between patients living with sickle cell disease and diabetes mellitus? African-Americans/ Black are the most affected by sickle cell disease (SCD). According to the US Department of Health and Human Services Office of Minority Health, this population also has the highest prevalence of obesity. Sickle cell …
Read More »Sodium-glucose cotransporter 2 inhibitors lower the risk of hospitalization in heart failure and cardiovascular death… The SIMPLE trial examined the effects of empagliflozin on myocardial flow reserve, showing microvascular perfusion in individuals with type 2 diabetes with high CVD risk. The SIMPLE trial is a single-center, double-blind, randomized clinical trial …
Read More »Controlling your blood sugar is more important than you think in the ICU… Glycemic control for patients is considered one of the most important factors when treating patients in an intensive care unit. Hyperglycemia statistically is deemed to be related to increased mortality and or morbidity. It is also an …
Read More »Which subgroup of patients with type 2 diabetes and heart failure is more beneficial from treatment with canagliflozin? Patients with type 2 diabetes are at risk for many cardiovascular diseases, including heart failure. In a cohort study published by Nichols et al., patients with type 2 diabetes are more likely …
Read More »New retrospective study results compare the two most largely prescribed antidiabetic medication classes in addition to metformin, to determine the impact on the incidence of CV events in patients with T2DM. Dipeptidyl-peptidase-4 inhibitors (DPP-4i) and sulphonylureas (sulfonylureas in the US) (SU) are two of the most prescribed medication to date …
Read More »A comprehensive study reveals the importance of ophthalmologic and otologic care in patients with T2DM due to the association of increased risks for cardiovascular events in those with a decline in vision and hearing abilities. It is known that patients with type 2 diabetes mellitus (T2DM) have an increased risk …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.